Retraction notices

EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E–Mutant NSCLC Cell Lines

Type

Retraction

Notice date

10/2/2017 0:00

Journal

Molecular Cancer Therapeutics

Publisher

American Association for Cancer Research

Notice DOI

10.1158/1535-7163.mct-17-0547

Original paper DOI

10.1158/1535-7163.mct-15-0375

Reasons

• Error in Cell Lines/Tissues
• Error in Data
• Error in Results and/or Conclusions

Matching venue names

Name match only, not an authoritative journal identifier.

• Molecular Cancer Therapeutics